The Federal Medical Centre (FMC), Abuja, has refuted claims circulating on social media that anti-snake venom was unavailable during the treatment of the late Ifunanya Lucy Nwagene, a fast-rising Nigerian musician who died after suffering a snake bite.
In a press statement issued on Sunday, the hospital clarified that Nwagene died from severe neurotoxic complications resulting from the snake bite she sustained on January 31, 2026. The management described her death as tragic and expressed condolences to her family and loved ones.
According to the statement, signed by the Head of Clinical Services, Dr Bioku Muftau, the hospital’s medical team responded promptly and professionally immediately after the patient arrived at the facility. Emergency care was said to have included resuscitation, administration of intravenous fluids, intranasal oxygen support, and the use of polyvalent anti-snake venom.
“Our medical staff provided immediate and appropriate treatment upon her arrival. Anti-snake venom was administered, and all standard emergency protocols were strictly followed,” the statement read.
The hospital explained that a rapid clinical assessment revealed that the victim had already developed severe neurotoxic effects from the bite. Arrangements were subsequently made to transfer her to the Intensive Care Unit (ICU) for advanced treatment.
However, FMC Abuja said her condition deteriorated suddenly moments before the transfer could be completed. Despite intensive resuscitation efforts, including cardiopulmonary resuscitation (CPR), the medical team was unable to revive her.
The management firmly rejected allegations of negligence, inadequate medical response, or non-availability of anti-venom, describing such claims as unfounded and misleading. It maintained that the quality of care provided was consistent with established medical standards.
FMC Abuja urged the public to rely on verified and credible sources of information rather than unconfirmed social media reports. The hospital reaffirmed its commitment to transparency, professionalism and patient safety, noting that it remains open to further engagement as public concern continues over access to life-saving drugs and emergency healthcare response.
